NEW YORK -Wednesday 10 October 2018 [ AETOS Wire ]
(BUSINESS WIRE)-- BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced the addition of top public affairs and technology experts to its U.S. team: Terry Neal has joined the firm as Executive Vice President, Managing Director, Public Affairs and James Cook has joined as Executive Vice President, Managing Director, New York Technology. Neal is based in Washington, D.C. and Cook is based in New York.
“Terry and James represent the high caliber of talent that BCW attracts, which makes us such a powerful partner to our clients,” said Chris Foster, President, North America, BCW. “Both Terry and James are world-class counselors with deep experience working with Fortune 100 clients and developing integrated communications solutions that make an impact on clients’ bottom lines. I am confident that Terry’s background in journalism and his expertise in advising on
...
Read more »
Views:
151
|
Added by:
africa-live
|
Date:
10.11.2018
|
|
OXFORD, England-Wednesday 10 October 2018 [ AETOS Wire ]
(BUSINESS WIRE) -- MinIT, a rapid analysis and device control accessory for nanopore DNA sequencing, is now arriving with genomics researchers. Scientists will use it to run the MinION DNA/RNA sequencer, opening up high-throughput, real-time nanopore sequencing to more users in more locations.
MinIT is equipped with a state-of-the-art NVIDIA AGX system, to enable real-time, high-throughput data analysis. It is preconfigured with software for quick setup and easy operation of the MinION. The pocket sized MinIT is powered by mains or separately available battery packs, so that it can be used either in a lab environment or out in the field.
Since its introduction in 2014 and commercial launch in 2015, the volume of DNA sequence data produced by a single MinION Flow Cell has increased more than 100-fold. With the latest ‘Rev-D’ chip, released last week, users can generate as much as 30Gb of data
...
Read more »
|
LONDON-Wednesday 10 October 2018 [ AETOS Wire ]
(BUSINESS WIRE)-- Japan has overtaken Singapore to claim the top spot on the 2018 Henley Passport Index, having gained visa-free access to Myanmar this month. Japan now enjoys visa-free/visa-on-arrival access to 190 destinations, compared to Singapore’s total of 189. The countries have been neck and neck since they both climbed to 1st place in February, pushing Germany down to 2nd place for the first time since 2014.
Germany has now fallen further to 3rd place, which it shares with South Korea and France. Their nationals enjoy visa-free access to 188 countries. France moved up a place last Friday when it gained visa-free access to Uzbekistan. Iraq and Afghanistan continues to sit at the bottom (106th) of the Henley Passport Index — based on exclusive data from the International Air Transport Association (IATA).
The US and the UK, both with 186 destinations, have slid down yet another spot — fro
...
Read more »
|
INGELHEIM, Germany & INDIANAPOLIS, Ind.-Wednesday 10 October 2018 [ AETOS Wire ]
Survival estimates from the EMPA-REG OUTCOME® trial data demonstrate potential long-term benefit of empagliflozin (marketed as Jardiance®) on life expectancy of adults with type 2 diabetes and cardiovascular disease1
(BUSINESS WIRE) -- Today, the journal Circulation published novel results based on data from the landmark EMPA-REG OUTCOME® trial, which suggest that treatment with empagliflozin positively impacts life expectancy in adults with type 2 diabetes and established cardiovascular disease. Using actuarial methods*, and assuming that the demonstrated beneficial effects of empagliflozin remain consistent with long-term use, empagliflozin was estimated to extend life expectancy by 1 to 4.5 years on average, depending on age, when compared with placebo.1 This analysis suggests that treatment with empagliflozin could add years of life.<
...
Read more »
Views:
149
|
Added by:
africa-live
|
Date:
10.11.2018
|
|
(BUSINESS WIRE)-- Starbucks Corporation (NASDAQ: SBUX) today announced Patrick Grismer has been appointed executive vice president and chief financial officer (cfo). Reporting to Kevin Johnson, Starbucks president and chief executive officer, Grismer succeeds Scott Maw, who will retire on November 30. Maw will remain a senior consultant through March 2019 to ensure a smooth transition, with Grismer joining the company on November 12 and assuming the role of cfo on November 30.
Grismer is an accomplished finance executive, bringing to Starbucks significant leadership experience at global, consumer-facing growth companies, including more than 25 years combined at Hyatt Hotels Corporation, Yum! Brands (parent company to KFC, Pizza Hut and Taco Bell) and The Walt Disney Company.
Grismer joins Starbucks from his current position as cfo of Hyatt, which he has held since joining the company in March 2016. In this role, he was responsible for all facets of the global finance
...
Read more »
Views:
160
|
Added by:
africa-live
|
Date:
10.11.2018
|
|
Data from five pivotal Phase 3 studies submitted as the basis for Marketing Authorisation Application for esketamine nasal spray
BEERSE, Belgium-Wednesday 10 October 2018 [ AETOS Wire ]
(BUSINESS WIRE)-- FOR MEDICAL AND TRADE MEDIA ONLY
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval for esketamine nasal spray, a glutamate receptor modulator, for treatment-resistant depression (TRD) in adults with Major Depressive Disorder (MDD) who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.
Esketamine nasal spray is an investigational product for the treatment of TRD that is being studied as part of a global development programme. As a glutamate receptor modulator, esketamine nasal spray is a rapidly-acting antidepressant that i
...
Read more »
|
PARIS LA DÉFENSE-Thursday 11 October 2018 [ AETOS Wire ]
(BUSINESS WIRE) -- Regulatory News:
Reference is made to the joint press release by Thales (Euronext Paris: HO) and Gemalto (Euronext Amsterdam and Paris: GTO) dated 27 March 2018 in relation to the launch of the recommended all-cash offer by Thales for all the issued and outstanding shares of Gemalto (the “Offer”), the publication of the Offer Document, and the joint press release of Thales and Gemalto dated 10 August 2018 in relation to the further extension of the Acceptance Period. Terms not defined in this press release will have the meaning as set forth in the Offer Document.
The contemplated combination is progressing satisfactorily: 6 of the required 14 regulatory clearances have already been obtained, and the steps to obtain the remaining eight1 are well advanced.
Thales and Gemalto are discussing with certain antitrust authorities on remedy proposals to address their concer
...
Read more »
|
TOKYO-Wednesday 10 October 2018 [ AETOS Wire ]
(BUSINESS WIRE) -- NTT DOCOMO, INC. (DOCOMO) announced today that it has added Wi-Fi® functionality to its Japan Welcome SIMTM prepaid SIM card service to provide travelers to Japan with fast and easy access to “docomo Wi-Fi” hotspots nationwide without any complicated set-up.
The new Japan Welcome SIM & Wi-FiTM service provides access to docomo Wi-Fi secure public wireless LAN hotspots across Japan, including sightseeing spots, train stations, airports and cafes.
Despite improvements to Japan’s public wireless LAN in the lead-up to 2020, a survey conducted by the Japan Tourism Agency found that the biggest complaint inbound travelers have when using Wi-Fi is the cumbersome authentication process. DOCOMO’s authenticated SIM, however, overcomes this by seamlessly switching between the DOCOMO mobile network and docomo Wi-Fi hotspots.
In conjunction with the service enhancemen
...
Read more »
|
SUMMIT, N.J.-Wednesday 10 October 2018 [ AETOS Wire ]
Ozanimod showed effects on cognitive processing speed in a post hoc analysis of 12-month data from SUNBEAM™ pivotal trial
In separate post hoc analysis of pooled data from phase 3 RADIANCE™ Part B and SUNBEAM trials, ozanimod reduced annualized relapse rates and MRI lesions at 12 months in patients with a disease state defined as early relapsing multiple sclerosis compared with patients with more advanced disease
(BUSINESS WIRE) -- Celgene Corporation (NASDAQ:CELG) today announced the results of two post hoc analyses of data from the phase 3 SUNBEAM™ and RADIANCE™ Part B trials, which evaluated the efficacy and safety of ozanimod, a novel, oral, selective sphingosine 1-phosphate 1 (S1P1) and 5 (S1P5) receptor modulator, versus a first-line treatment, Avonex® (interferon beta-1a) (IFN), in patients with relapsing multiple sclerosis (RMS). These findings will be presented at ECTRI
...
Read more »
|
Dubai, United Arab Emirates, -Wednesday 10 October 2018 [ AETOS Wire ]
Anghami (the leading music streaming company in the MENA region) successfully hosted its “Anghami for Brands Annual Gathering” on Wednesday, September 26 in Dubai. The invite-only event was organized with the support of Anghami’s Exclusive Media Representative - Digital Media Services (DMS), the digital arm of Choueiri Group.
The event covered the latest Anghami app updates, new advertising solutions and the announcement of the vision to double up on collaborations with the music community to support the rising scene, fill gaps in the Arabic music scene and bridge the East and West.
Rami Zeidan, Anghami’s VP of Partnerships, set the tone for the day’s forward looking, fun-filled and musically charged agenda and stated “Today is all about celebrating how far Anghami has come since we started. Thanks to all of you and the power of music, we have grown to b
...
Read more »
Views:
179
|
Added by:
africa-live
|
Date:
10.11.2018
|
| |